Cost-effectiveness analysis: A tool in the hands of the clinician

被引:2
|
作者
De Carlo, Marco [1 ]
机构
[1] Azienda Osped Univ Pisana, Cardiothorac & Vasc Dept, Pisa, Italy
关键词
RIVAROXABAN; ASPIRIN; DISEASE;
D O I
10.1177/2047487318822357
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:855 / 857
页数:3
相关论文
共 50 条
  • [41] Cost-effectiveness of rotavirus vaccination in Albania
    Ahmeti, Albana
    Preza, Iria
    Simaku, Artan
    Nelaj, Erida
    Clark, Andrew David
    Garcia, Ana Gabriela Felix
    Lara, Carlos
    Hoestlandt, Celine
    Blau, Julia
    Bino, Silvia
    VACCINE, 2015, 33 : A201 - A208
  • [42] Cost-Effectiveness Analysis of Apixaban, Dabigatran, Rivaroxaban, and Warfarin for Stroke Prevention in Atrial Fibrillation in Taiwan
    Liu, Chieh-Yu
    Chen, Hui-Chun
    CLINICAL DRUG INVESTIGATION, 2017, 37 (03) : 285 - 293
  • [43] The cost-effectiveness of specific allergen immunotherapy
    Cohn, John R.
    ENT-EAR NOSE & THROAT JOURNAL, 2011, 90 (06) : 244 - 245
  • [44] Cost-Effectiveness of Bariatric Surgery in Tunisia
    Galvain, Thibaut
    Bosut, Melek Pinar
    Jamous, Nadine
    Ben Mansour, Nadia
    DIABETES METABOLIC SYNDROME AND OBESITY, 2023, 16 : 935 - 945
  • [45] The cost-effectiveness of rotavirus vaccination in Armenia
    Jit, Mark
    Yuzbashyan, Ruzanna
    Sahakyan, Gayane
    Avagyan, Tigran
    Mosina, Liudmila
    VACCINE, 2011, 29 (48) : 9104 - 9111
  • [46] Cost-effectiveness of anorexia nervosa in QALYs
    Pohjolainen, Veera
    Rasanen, Pirjo
    Roine, Risto P.
    Sintonen, Harri
    Koponen, Salla
    Karlsson, Hasse
    NORDIC JOURNAL OF PSYCHIATRY, 2017, 71 (01) : 67 - 71
  • [47] Cost-effectiveness of febuxostat in chronic gout
    Beard, Stephen M.
    von Scheele, Birgitta G.
    Nuki, George
    Pearson, Isobel V.
    EUROPEAN JOURNAL OF HEALTH ECONOMICS, 2014, 15 (05) : 453 - 463
  • [48] The Cost-Effectiveness of Rotavirus Vaccination in Malawi
    Berry, Stephen A.
    Johns, Benjamin
    Shih, Chuck
    Berry, Andrea A.
    Walker, Damian G.
    JOURNAL OF INFECTIOUS DISEASES, 2010, 202 : S108 - S115
  • [49] Analysis of the cost-effectiveness of treatment strategies for CML with incorporation of treatment discontinuation
    Yamamoto, Chihiro
    Nakashima, Hirotomo
    Ikeda, Takashi
    Kawaguchi, Shin-ichiro
    Toda, Yumiko
    Ito, Shoko
    Mashima, Kiyomi
    Nagayama, Takashi
    Umino, Kento
    Minakata, Daisuke
    Nakano, Hirofumi
    Morita, Kaoru
    Yamasaki, Ryoko
    Sugimoto, Miyuki
    Ishihara, Yuko
    Ashizawa, Masahiro
    Hatano, Kaoru
    Sato, Kazuya
    Oh, Iekuni
    Fujiwara, Shin-ichiro
    Ueda, Masuzu
    Ohmine, Ken
    Muroi, Kazuo
    Kanda, Yoshinobu
    BLOOD ADVANCES, 2019, 3 (21) : 3266 - 3277
  • [50] Optimal control and comprehensive cost-effectiveness analysis for COVID-19
    Asamoah, Joshua Kiddy K.
    Okyere, Eric
    Abidemi, Afeez
    Moore, Stephen E.
    Sun, Gui-Quan
    Jin, Zhen
    Acheampong, Edward
    Gordon, Joseph Frank
    RESULTS IN PHYSICS, 2022, 33